Reports for BAYER INC

Company Name
BAYER INC

Shortage reports

Actual shortage:

2 (2%)

Anticipated shortage:

0 (0%)

Avoided shortage:

11 (12%)

Resolved:

79 (86%)

92

Discontinuation Reports

To be discontinued:

0 (0%)

Discontinued:

22 (96%)

Reversed:

1 (4%)

23

5 (4%)

1 (50%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
GLUCOBAY 100MG TABLET Resolved 2019-03-29 2020-02-06 79881
GLUCOBAY 100MG TABLET Resolved 2017-07-17 2017-08-25 16073
GLUCOBAY 50MG TABLET Resolved 2022-03-17 2023-07-11 156826
GLUCOBAY 50MG TABLET Resolved 2018-12-14 2019-07-25 69617
GLUCOBAY 50MG TABLET Resolved 2017-07-17 2017-09-15 16068
LEVITRA 10MG TABLET Resolved 2018-10-18 2019-01-14 64770
LEVITRA 20MG TABLET Resolved 2020-04-28 2020-10-19 113348
LEVITRA 10MG TABLET Resolved 2019-01-14 2021-02-24 72120
LEVITRA 20MG TABLET Resolved 2018-07-13 2018-11-14 55646
LEVITRA 10MG TABLET Resolved 2018-03-23 2018-08-14 43751
LEVITRA 5MG TABLET Resolved 2018-05-16 2023-07-14 49555
LEVITRA 20MG TABLET Resolved 2021-12-08 2022-06-01 150771
STAXYN 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2018-09-21 2022-09-29 62147
ULTRAVIST 300 62% SOLUTION Resolved 2024-04-02 2024-09-05 224122
ULTRAVIST 300 62% SOLUTION Resolved 2024-01-12 2024-06-03 215772
ULTRAVIST 300 62% SOLUTION Resolved 2024-04-02 2024-12-16 224127
ULTRAVIST 370 77% SOLUTION Resolved 2024-01-12 2024-03-14 215790
ULTRAVIST 370 77% SOLUTION Resolved 2024-01-12 2024-05-06 215787
ULTRAVIST 370 77% SOLUTION Resolved 2024-02-07 2024-05-06 218759
ULTRAVIST 370 77% SOLUTION Resolved 2024-01-12 2024-08-21 215779

Showing 41 to 60 of 92

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
STAXYN 10MG TABLET (ORALLY DISINTEGRATING) Discontinued 2023-07-14 2023-07-14 198701
ULTRAVIST 240 50% SOLUTION Discontinued 2019-04-17 2019-04-17 81959
XARELTO 15MG 20MG TABLET KIT Discontinued 2018-12-05 2018-12-05 68808

Showing 21 to 23 of 23